Net Loss per Share

3 Months Ended

Mar. 31, 2020

Basic and diluted net loss per share have been computed using the weighted-average number of shares of common stock outstanding during the period. We have outstanding stock-based awards that are not used in the calculation of diluted net loss per share because to do so would be anti-dilutive.

The following instruments (in thousands) were excluded from the calculation of diluted net loss per share because their effects would be antidilutive:



	Three months ended March 31,
	2020	2019
Stock-based awards	16,662	12,431
Healios warrant – see Note 6	—	17,000
Total	16,662	29,431